Solithromycin is a ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia (CAP) and other infections. It is grouped under the following drug class(es): Macrolides. Its therapeutic use is listed as antibiotics. The directory classifies it as a under development API with a semi-synthetic source/manufacturing origin. Other names for this substance include solithromycine and solitromicina. Its PubChem CID is 25242512.
Solithromycin
| CAS No | 760981-83-7 |
|---|---|
| Molecular Formula | C43H65FN6O10 |
| Molecular Weight | 845.0 g/mol |
| Synonyms | (1S,2R,5S,7R,8R,9R,11R,13R,14R)-15-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-5-fluoro-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Solithromycin is a ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia (CAP) and other infections. It is grouped under the following drug class(es): Macrolides.
The listed CAS number is 760981-83-7.
The listed molecular formula is C43H65FN6O10.
The listed molecular weight is 845.0 g/mol.
(1S,2R,5S,7R,8R,9R,11R,13R,14R)-15-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-5-fluoro-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone.
The source lists solithromycine and solitromicina.